Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Roche Bondronat Approved in EUNervous system
Molecular Insight BMIPP accomplished Phase IICardiovascular system
Takeda Blopress Japan, EU, Asia Approved in USA, EU and JapanCardiovascular system
Adventrx BlockAide / CR in Phase IAnti-infectives for systemic use
BioSante BioVant accomplished Phase IAnti-infectives for systemic use
BioSante Bio-T-Gel accomplished Phase IIISystemic hormonal preparations
BioSante Bio-E-Gel Approved in USAGenito urinary system & sex hormones
Genvec Biobypass in Phase IICardiovascular system
BioPartners Biferonex Submitted for approval in EUNervous system
NitroMed BiDil Approved in USACardiovascular system
GlaxoSmithKline Bexxar Approved in USAAntineoplastic & immunomodulating agents
Pfizer Bextra Approved in EUMusculoskeletal system
IDM Pharma Bexidem in Phase IIIAntineoplastic & immunomodulating agents
Bayer Betaseron Approved in USANervous system
Bayer Betaferon Approved in EU, US and CanadaCardiovascular system
United Therapeutics Beraprost SR in Phase ICardiovascular system
Sankyo Benicar HCT Approved in USACardiovascular system
Bristol-Myers Squibb Basulin in Phase IIAlimentary tract & metabolism
Takeda Basen Approved in JapanAlimentary tract & metabolism
Bristol-Myers Squibb BARACLUDE Approved in EU, USA and JapanAnti-infectives for systemic use

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.